These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26485927)

  • 1. A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasive Breast Cancer.
    Shi JF; Sun MG; Li XY; Zhao Y; Ju RJ; Mu LM; Yan Y; Li XT; Zeng F; Lu WL
    J Biomed Nanotechnol; 2015 Sep; 11(9):1568-82. PubMed ID: 26485927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer.
    Sun MG; Shi JF; Li XY; Zhao Y; Ju RJ; Mu LM; Yan Y; Li XT; Zeng F; Lu WL
    J Biomed Nanotechnol; 2015 Aug; 11(8):1339-53. PubMed ID: 26295137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
    Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
    Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer.
    Zeng F; Ju RJ; Liu L; Xie HJ; Mu LM; Zhao Y; Yan Y; Hu YJ; Wu JS; Lu WL
    Oncotarget; 2015 Nov; 6(34):36625-42. PubMed ID: 26429872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer.
    Fu M; Tang W; Liu JJ; Gong XQ; Kong L; Yao XM; Jing M; Cai FY; Li XT; Ju RJ
    J Drug Target; 2020 Mar; 28(3):245-258. PubMed ID: 31462111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
    Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
    J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
    Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
    Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels.
    Ju RJ; Cheng L; Qiu X; Liu S; Song XL; Peng XM; Wang T; Li CQ; Li XT
    J Drug Target; 2018 Nov; 26(9):793-805. PubMed ID: 29334266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
    Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
    Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.
    Zhang D; Sun B; Zhao X; Ma Y; Ji R; Gu Q; Dong X; Li J; Liu F; Jia X; Leng X; Zhang C; Sun R; Chi J
    Mol Cancer; 2014 Sep; 13():207. PubMed ID: 25200065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells.
    Li RJ; Ying X; Zhang Y; Ju RJ; Wang XX; Yao HJ; Men Y; Tian W; Yu Y; Zhang L; Huang RJ; Lu WL
    J Control Release; 2011 Feb; 149(3):281-91. PubMed ID: 20971141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system.
    Yang Y; Yang Y; Xie X; Cai X; Wang Z; Gong W; Zhang H; Li Y; Mei X
    Colloids Surf B Biointerfaces; 2015 Apr; 128():427-438. PubMed ID: 25766920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.
    Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL
    Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma.
    Yu Y; Wang ZH; Zhang L; Yao HJ; Zhang Y; Li RJ; Ju RJ; Wang XX; Zhou J; Li N; Lu WL
    Biomaterials; 2012 Feb; 33(6):1808-20. PubMed ID: 22136714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells.
    Zhang L; Yao HJ; Yu Y; Zhang Y; Li RJ; Ju RJ; Wang XX; Sun MG; Shi JF; Lu WL
    Biomaterials; 2012 Jan; 33(2):565-82. PubMed ID: 21983136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC.
    Kong L; Zhang SM; Chu JH; Liu XZ; Zhang L; He SY; Yang SM; Ju RJ; Li XT
    Int J Nanomedicine; 2020; 15():6451-6468. PubMed ID: 32922011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
    Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
    Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
    Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
    Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.